Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Accumulating evidence from animal studies suggests that the corticotropin releasing hormone (CRH) and arginine vasopressin (AVP) neuropeptide systems, contribute to anxiety behavior. To investigate whether polymorphisms in the genes regulating these two systems may alter susceptibility to anxiety disorders in humans, we genotyped 71 single nucleotide polymorphisms (SNPs) in CRH, CRHR1, CRHR2, AVP, AVPR1A, AVPR1B in a German sample from Munich with patients suffering from panic disorder and matched healthy controls (n = 186/n = 299). Significant associations were then replicated in a second German sample with 173 patients with panic disorder and 495 controls. In both samples separately and the combined sample, SNPs within CHRH1 and AVPR1B were nominally associated with panic disorder. We then tested two locus multiplicative and interaction effects of polymorphisms of these two genes on panic disorder. Fifteen SNP pairs showed significant multiplicative effects in both samples. The SNP pair with the most significant association in the combined sample (P = 0.00057), which withstood correction for multiple testing, was rs878886 in CRHR1 and rs28632197 in AVPR1B. Both SNPs are of potential functional relevance as rs878886 is located in the 3′ untranslated region of the CRHR1 and rs28632197 leads to an arginine to histidine amino acid exchange at position 364 of AVPR1B which is located in the intracellular C‐terminal domain of the receptor. These data suggest that polymorphisms in the AVPR1B and the CRHR1 genes alter the susceptibility to panic disorder. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robins, L. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360017003 · Cited by 2,909 · cited 1×
“%) criteria on the basis of structured interviews (SADS-LA: [Manuzza et al., 1986], CIDI: [Robins et al., 1988], SCID-I: [Wittchen, 1997]) and clinical records as previously described [Domschke et al., 2007].”
BackgroundReplication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194 · cited 1×
“A number of linkage and candidate gene association studies have been published for panic disorder [Hamilton et al., 2001; Sen et al., 2004; Van West and Claes, 2004; Cheng et al., 2006; Zeggini et al., 2007].”
BackgroundSwanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953 · cited 1×
“Also in behaviorally relevant limbic brain regions, AVP and CRH systems are overlapping and while direct co-localization of CRHR1 and AVPR1B has not been reported yet, their overlapping expression pattern in limbic brain regions such as hippocampus and amygdala is suggestive of it [Swanson et al., 1983; Barberis and T…”
BackgroundDunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
JACOBI, F., WITTCHEN, H.-U., HÖLTING, C., HÖFLER, M., PFISTER, H., MÜLLER, N., & LIEB, R. (2004) · Psychological Medicine · doi:10.1017/s0033291703001399 · Cited by 1,097 · cited 1×
“All patients underwent the Structured Clinical Interviews for DSM-IV (SCID I and II) [Jacobi et al., 2004].”
MethodSelf-citationBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 1×
“A total of 71 SNPs were selected, from public and private databases (dbSNP (http://www.ncbi.nlm.nih. gov:80/) and Celera, Inc. (http://www.celeradiscoverysystem. com/)) and 4 have been identified through resequencing of the DNA of 94 depressed patients [Binder et al., 2004] (see also Table II).”
BackgroundSelf-citationZobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Self-citationWittchen, H.-U., Lachner, G., Wunderlich, U., & Pfister, H. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050095 · Cited by 668 · cited 1×
“Controls were selected randomly from a Munich-based community sample and screened for the presence of anxiety and affective disorders using the Composite International Diagnostic-Screener [Wittchen et al., 1998].”
MethodCoplan, J. D., Andrews, M. W., Rosenblum, L. A., Owens, M. J., Friedman, S., Gorman, J. M., & Nemeroff, C. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1619 · Cited by 649 · cited 2×
“This HPA axis disturbance has been proposed to be involved in higher susceptibility to lactateinduced panic attacks [Coplan et al., 1996] as well as shortand long-term outcome of panic disorder [Coryell et al.”
BackgroundVasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Antoni, F. A. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1004 · Cited by 636
Cited by
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology
Martin, E. I., Ressler, K. J., Binder, E., & Nemeroff, C. B. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.05.004 · Cited by 557
Self-citationVasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
Key role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
The CRF system, stress, depression and anxiety—insights from human genetic studies
Binder, E. B., & Nemeroff, C. B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.141 · Cited by 379
Self-citationThe Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 260
microRNA as Repressors of Stress-Induced Anxiety: The Case of Amygdalar miR-34
Haramati, S., Navon, I., Issler, O., Ezra-Nevo, G., Gil, S., Zwang, R., Hornstein, E., & Chen, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1673-11.2011 · Cited by 252
“…in the stress response is well documented and was studied in the context of different neuromodulators, such as corticotropin releasing factor (CRF) (Koob and Heinrichs, 1999; Keen-Rhinehart et al., 2009; Jankord and Herman, 2008), Oxytocin (Bosch et al., 2005; Ebner et al., 2005), and others.”
BackgroundNeuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194
Self-citationMuiños-Gimeno, M., Espinosa-Parrilla, Y., Guidi, M., Kagerbauer, B., Sipilä, T., Maron, E., Pettai, K., Kananen, L., Navinés, R., Martín-Santos, R., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.010 · Cited by 187
HPA axis genetic variation, cortisol and psychosis in major depression
Schatzberg, A. F., Keller, J., Tennakoon, L., Lembke, A., Williams, G., Kraemer, F. B., Sarginson, J. E., Lazzeroni, L. C., & Murphy, G. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.129 · Cited by 131
“Genetic variation at the corticotrophin releasing hormone (CRH) locus, in the genes encoding its binding protein and type 1 and 2 receptors have been associated with increased risk for developing panic disorder (19), post-traumatic stress disorder and major depression (20) particularly in the face of early abuse (21-2…”
Genetic approaches to hypothalamic-pituitary-adrenal axis regulation
Arnett, M. G., Muglia, L. M., Laryea, G., & Muglia, L. J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.215 · Cited by 105
Evidence for the role of corticotropin-releasing factor in major depressive disorder
Waters, R. P., Rivalan, M., Bangasser, D. A., Deussing, J. M., Ising, M., Wood, S. K., Holsboer, F., & Summers, C. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.011 · Cited by 93
“In addition, SNPs for CRF1 and vasopressinergic V1B receptors were associated with panic disorder (Keck et al., 2008).”
BackgroundSelf-citationThe CRF system as a therapeutic target for neuropsychiatric disorders
Sanders, J., & Nemeroff, C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.09.004 · Cited by 72
CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?
Schartner, C., Ziegler, C., Schiele, M. A., Kollert, L., Weber, H., Zwanzger, P., Arolt, V., Pauli, P., Deckert, J., Reif, A., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.01.005 · Cited by 53
Self-citationAnxiety in mice and men: a comparison
Hohoff, C. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0215-z · Cited by 50
“Emerging evidence from studies in mice suggests epigenetic processes involved in regulating the genome to develop stable alterations in phenotype ( Jirtle and Skinner 2007; Weaver 2007).”
BackgroundSelf-citationCRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues
Risbrough, V. B., Geyer, M. A., Hauger, R. L., Coste, S., Stenzel-Poore, M., Wurst, W., & Holsboer, F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.205 · Cited by 49
“Mutations in the CRF (Smoller et al, 2005) and CRF1 receptor (Keck et al, 2008) genes have been associated with traits predictive for panic disorder and panic disorder diagnoses, respectively.”
BackgroundSelf-citationPossible genetic association between vasopressin receptor 1B and child aggression
Zai, C. C., Muir, K. E., Nowrouzi, B., Shaikh, S. A., Choi, E., Berall, L., Trépanier, M.-O., Beitchman, J. H., & Kennedy, J. L. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.031 · Cited by 43
“AVPR1B has also been associated with panic disorder in a German study (Keck et al., 2008).”
BackgroundEmerging drugs for panic disorder
Perna, G., Guerriero, G., & Caldirola, D. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.628313 · Cited by 23
“In rats, CRF type 1 (CRF-1) receptor is mostly present in brainstem, cerebellum, cortex and limbic system, all of which are areas potentially involved in PD, and, in humans, polymorphisms in CRF-1 receptor gene have been associated with PD [95].”
BackgroundKazantseva, A. V., Kutlumbetova, Y. Y., Malykh, S. B., Lobaskova, M. M., & Khusnutdinova, E. K. (2014) · Russian Journal of Genetics · doi:10.1134/s1022795414030041 · Cited by 11
“According to the published data, AVPR1B gene poly morphisms were associated with depression [16], panic disorder [9], and child aggression [8].”
BackgroundResult
Metadata
- Authors
- Keck, M. E., Kern, N., Erhardt, A., Unschuld, P. G., Ising, M., Salyakina, D., Müller, M. B., Knorr, C. C., Lieb, R., Hohoff, C., Krakowitzky, P., Maier, W., Bandelow, B., Fritze, J., Deckert, J., Holsboer, F., Müller‐Myhsok, B., & Binder, E. B.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2008-04-02
- Volume
- 147B
- Issue
- 7
- Pages
- 1196-1204
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2003654636
- Cited by
- 112
- References
- 15
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.